Cargando…

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype

BACKGROUND: Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT ≥ 3.5 mm. However, there is no current global consensus on the cutoff va...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Linjuan, Huang, Hailong, An, Gang, Cai, Meiying, Wu, Xiaoqing, Li, Ying, Xie, Xiaorui, Lin, Yuan, Wang, Meiying, Xu, Liangpu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687862/
https://www.ncbi.nlm.nih.gov/pubmed/31209990
http://dx.doi.org/10.1002/mgg3.811
_version_ 1783442794402021376
author Su, Linjuan
Huang, Hailong
An, Gang
Cai, Meiying
Wu, Xiaoqing
Li, Ying
Xie, Xiaorui
Lin, Yuan
Wang, Meiying
Xu, Liangpu
author_facet Su, Linjuan
Huang, Hailong
An, Gang
Cai, Meiying
Wu, Xiaoqing
Li, Ying
Xie, Xiaorui
Lin, Yuan
Wang, Meiying
Xu, Liangpu
author_sort Su, Linjuan
collection PubMed
description BACKGROUND: Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT ≥ 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test. METHODS: Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT ≥ 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. RESULTS: Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5–3.4 mm, and 55 fetuses with NT ≥ 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one  likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT ≥ 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05). CONCLUSION: CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5–3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.
format Online
Article
Text
id pubmed-6687862
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66878622019-08-14 Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype Su, Linjuan Huang, Hailong An, Gang Cai, Meiying Wu, Xiaoqing Li, Ying Xie, Xiaorui Lin, Yuan Wang, Meiying Xu, Liangpu Mol Genet Genomic Med Original Articles BACKGROUND: Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT ≥ 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test. METHODS: Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT ≥ 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. RESULTS: Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5–3.4 mm, and 55 fetuses with NT ≥ 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one  likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT ≥ 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05). CONCLUSION: CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5–3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed. John Wiley and Sons Inc. 2019-06-17 /pmc/articles/PMC6687862/ /pubmed/31209990 http://dx.doi.org/10.1002/mgg3.811 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Su, Linjuan
Huang, Hailong
An, Gang
Cai, Meiying
Wu, Xiaoqing
Li, Ying
Xie, Xiaorui
Lin, Yuan
Wang, Meiying
Xu, Liangpu
Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
title Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
title_full Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
title_fullStr Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
title_full_unstemmed Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
title_short Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
title_sort clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687862/
https://www.ncbi.nlm.nih.gov/pubmed/31209990
http://dx.doi.org/10.1002/mgg3.811
work_keys_str_mv AT sulinjuan clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT huanghailong clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT angang clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT caimeiying clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT wuxiaoqing clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT liying clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT xiexiaorui clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT linyuan clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT wangmeiying clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype
AT xuliangpu clinicalapplicationofchromosomalmicroarrayanalysisinfetuseswithincreasednuchaltranslucencyandnormalkaryotype